Cha AI Healthcare Co., Ltd. (KRX:025620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,200.00
+160.00 (3.17%)
Aug 31, 2026, 3:30 PM KST

Cha AI Healthcare Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
8,4357,30515,67516,0896,24614,978
Other Revenue
---0--0-0
8,4357,30515,67516,0896,24614,978
Revenue Growth
-5.37%-53.40%-2.57%157.58%-58.30%-50.92%
Cost of Revenue
6,1105,2418,3248,1235,34214,261
Gross Profit
2,3252,0647,3517,966904.53716.44
Selling, General & Admin
8,6728,34214,31617,1699,23910,543
Other Operating Expenses
18.523.4453.6192.1986.36115.14
Operating Expenses
10,5559,76714,08017,3208,88818,850
Operating Income
-8,230-7,702-6,728-9,354-7,983-18,133
Interest Expense
-3,099-1,083-122.87-109.53-484.8-1,737
Interest & Investment Income
944.88834.43832.29393.7198.6238.31
Earnings From Equity Investments
4,451-316.92--4,593-9,456
Currency Exchange Gain (Loss)
437.47-48.3263.3946.81128.1153.89
Other Non Operating Income (Expenses)
22,98012,449777.59741.271,923-165.97
EBT Excluding Unusual Items
17,4844,450-4,661-8,282-10,811-29,301
Impairment of Goodwill
------1,028
Gain (Loss) on Sale of Investments
-11,727-3,083-3,3902,969-1,4083,023
Gain (Loss) on Sale of Assets
11-6.66-97.6979.33-3.76
Asset Writedown
-0.47-0.47-225.97-545.88-7,371-8,618
Pretax Income
8,1591,367-8,283-5,957-19,511-35,927
Income Tax Expense
--1,51910.22--42.1
Earnings From Continuing Operations
8,1591,367-9,802-5,967-19,511-35,885
Earnings From Discontinued Operations
--308.49-830.54-2,192-3,921
Net Income to Company
8,1591,367-9,493-6,798-21,703-39,805
Minority Interest in Earnings
-15.3900.280.72268.621,241
Net Income
8,1441,367-9,493-6,797-21,435-38,564
Net Income to Common
8,1441,367-9,493-6,797-21,435-38,564
Net Income Growth
------
Shares Outstanding (Basic)
1484433
Shares Outstanding (Diluted)
1484433
Shares Change
200.57%69.01%2.71%54.22%-3.40%42.72%
EPS (Basic)
574.41180.75-2121.68-1560.23-7588.09-13187.50
EPS (Diluted)
574.41180.75-2122.05-1560.23-7588.09-13187.50
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6,126-6,712-7,128-9,947-5,901-3,732
Free Cash Flow Per Share
-432.04-887.58-1592.97-2283.42-2088.95-1276.25
Gross Margin
27.56%28.26%46.90%49.51%14.48%4.78%
Operating Margin
-97.58%-105.44%-42.92%-58.14%-127.81%-121.07%
Profit Margin
96.55%18.71%-60.56%-42.24%-343.16%-257.48%
Free Cash Flow Margin
-72.62%-91.88%-45.47%-61.83%-94.47%-24.92%
EBITDA
-7,382-6,947-6,161-8,794-7,031-16,390
EBITDA Margin
-87.52%-95.10%-39.30%-54.66%-112.56%-109.43%
D&A For EBITDA
848.59754.98567.15560.32952.461,743
EBIT
-8,230-7,702-6,728-9,354-7,983-18,133
EBIT Margin
-97.58%-105.44%-42.92%-58.14%-127.81%-121.07%
Advertising Expenses
-477.544,5675,1861,279775.41